Perfluoroctylbromide as a Blood Pool Contrast Agent for Liver, Spleen, and Vascular Imaging in Computed Tomography
- 1 August 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 8 (4) , 739-744
- https://doi.org/10.1097/00004728-198408000-00028
Abstract
Perfluoroctylbromide (PFOB) in emulsion form was tested as a blood pool imaging agent for computed tomography (CT) in 5 animals (3 dogs and 2 pigs). Computed tomography of the kidneys, liver, spleen and mediastinum was performed in the control state and at various time intervals after the end of PFOB infusion. The attenuation coefficient of the vascular space increased by 117 Hounsfield units (HU) (range 105-128 HU), the liver by 54 HU (range 43-70 HU), and the spleen by 77 HU (range 69-86 HU) 30 to 50 min after the end of PFOB infusion, 5 ml/kg. The vascular space enhanced by 25 HU for every g of PFOB/100 ml of blood and remained at almost a constant level for hours after the end of infusion. PFOB emulsion, in addition to hepatosplenic enhancement, evidently produces prolonged and substantial opacification of the vascular space, allowing CT imaging of the heart and vascular structures minutes to hours after the end of infusion.This publication has 8 references indexed in Scilit:
- Perfluoroctylbromide: Acute Hemodynamic Effects, in Pigs, of Intravenous Administration Compared With the Standard Ionic Contrast MediaInvestigative Radiology, 1984
- Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.Radiology, 1982
- EOE-13 in the detection of hepatosplenic lymphoma.Radiology, 1982
- Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxisBlood, 1982
- Evaluation of the hemodynamic effects of intravenous administration of ionic and nonionic contrast materials. Implications for deriving physiologic measurements from computed tomography and digital cardiovascular imaging.Radiology, 1982
- A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.Radiology, 1980
- Perfluoroctylbromide as a Diagnostic Contrast Medium in GastroenterographyRadiology, 1977
- Extravascular Contrast Material: The Major Component of Contrast EnhancementRadiology, 1976